Review of the Emerging Evidence Demonstrating the Efficacy of Ivermectin in the Prophylaxis and Treatment of COVID-19 American Journal of Therapeutics: May Jun 2021 – Volume 28 – Issue 3 – p e299-e318. doi: 10.1097/MJT.0000000000001377 Read the full article here. Abstract Background: After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, […]
The Economic Standard is proud to present our first white paper. We demonstrate through meticulously sourced analysis: 1) Hydroxychloroquine (HCQ) is a safe, versatile medicine that has treated hundreds of millions of people for many diseases over seven decades. 2) Numerous controlled observational studies and meta-analyses have demonstrated that HCQ can help […]
By Erik Sass, TES Editor-in-Chief Following is a compilation of randomized controlled trials (and other types of studies) of hydroxychloroquine as a treatment for COVID-19, listing the flaws and errors which invalidate their conclusions. To add a trial entry or send corrections, please email TES Editor-in-Chief Erik Sass: eriksass@gmail.com . Boulware, et al. […]